:: Altroz - News Magazine HTML Template ::

Aurobindo Pharma's Subsidiary Ends Partnership with Hilleman Labs on Pediatric Vaccine Development

Olivia Carter 07 Mar, 2025

Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd, has terminated its licensing agreement with Hilleman Laboratories for a pediatric pentavalent vaccine. The termination, effect...

Business

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Ryan Peterson 18 Dec, 2024

Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...

Business

Aurobindo Pharma's CuraTeQ Secures Positive EMA Opinion for Zefylti Biosimilar

Emily Rodriguez 17 Dec, 2024

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received a positive opinion from EMA's CHMP for its filgrastim biosimilar, Zefylti. This marks the first biosimilar from Aurobi...

Aurobindo Pharma News

Aurobindo Pharma's Subsidiary Ends Partnership with Hilleman Labs on Pediatric Vaccine Development

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Aurobindo Pharma's CuraTeQ Secures Positive EMA Opinion for Zefylti Biosimilar

Popular News

Bitcoin Plummets Below $98K Amid Trump's Escalating Trade War

Taihan Cable & Solution Poised for Robust Growth with Projected Strong Orders and Earnings by 2025

December Sees a 0.7% Dip in Japan's Retail Sales, Yet Annual Figures Show Growth

Paytm's Q3 Financials Revealed: A Deep Dive into the Rs 208 Crore Loss and Revenue Drop

European Markets Dip Premarket as Investors Eye Major Earnings Reports

U.S. Jobless Claims Rise Slightly to 223,000, Signaling Labor Market Resilience

India's AI Investment Skyrockets: Set to Outpace Digital Tech Growth by 2.2x, Eyeing $115 Billion Economic Boom by 2027

Nestaway Co-founder Accuses Major Investors of Fraud and Conspiracy

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us